Beginning Cash: The amount of cash reported by the company on its previous statement.
ZyVersa Therapeutics, Inc. (ZVSA) had Beginning Cash of $1.53M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.26M |
|
-- |
|
-- |
|
$2.14M |
|
$-2.14M |
|
$-0.13M |
|
$-2.26M |
|
$-2.26M |
|
$-2.26M |
|
$-2.26M |
|
$-2.26M |
|
$-2.26M |
|
$-2.14M |
|
$-2.14M |
|
3.11M |
|
3.11M |
|
$-0.73 |
|
$-0.73 |
|
| Balance Sheet Financials | |
$2.11M |
|
-- |
|
$18.88M |
|
$20.99M |
|
$12.00M |
|
-- |
|
$0.85M |
|
$12.86M |
|
$8.13M |
|
$-10.52M |
|
$8.13M |
|
2.57M |
|
| Cash Flow Statement Financials | |
$-1.77M |
|
-- |
|
$1.85M |
|
|
Beginning Cash |
$1.53M |
$1.61M |
|
$0.08M |
|
$0.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.76% |
|
21.46% |
|
-10.75% |
|
-27.76% |
|
$3.17 |
|
$-0.57 |
|
$-0.57 |
|